Public Health On Call · Apr 2, 2026 · 15:03
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Prediabetes—a diagnosis characterized by elevated blood sugar levels that can progress to Type 2 diabetes—is embroiled in debate about whether the condition is clinically "real," and, if so, what the threshold for diagnosis should be. In this episode: Epidemiologist and diabetes expert Elizabeth Selvin breaks down the controversy surrounding prediabetes and why she thinks the diagnosis offers an opportunity for intervention.
Guest:Elizabeth Selvin, PhD, MPH, is a professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where she studies diagnosis and screening for diabetes and prediabetes.
Host:Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department.
Show links and related content:Prediabetes and What It Means: The Epidemiological Evidence—Annual Review of Public Health
Prediabetes Explained: An Under-the-Radar and Common Condition That Doesn't Have to Lead to a Diabetes Diagnosis—Johns Hopkins Bloomberg School of Public Health
In Praise of Prevention—Hopkins Bloomberg Public Health Magazine
Diabetes Prevention Program (DPP)—National Institute of Diabetes and Digestive and Kidney Diseases
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
FollowEpisodes: Public Health On Call